These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 65308)

  • 41. A new class of monoamine oxidase inhibitors.
    Vunnam RR; Bond D; Schatz RA; Radin NS; Narasimhachari N
    J Neurochem; 1980 Feb; 34(2):410-6. PubMed ID: 7411153
    [No Abstract]   [Full Text] [Related]  

  • 42. Contribution of monoamine oxidase(MAO) to the binding of tertiary basic drugs in isolated perfused rat lung.
    Yoshida H; Okumura K; Hori R
    Pharm Res; 1990 Apr; 7(4):398-401. PubMed ID: 2362915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria.
    Ekstedt B
    Biochem Pharmacol; 1976 May; 25(10):1133-8. PubMed ID: 938537
    [No Abstract]   [Full Text] [Related]  

  • 44. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1974 Sep; 23(18):2537-45. PubMed ID: 4412708
    [No Abstract]   [Full Text] [Related]  

  • 45. Substituted xanthones as selective and reversible monoamine oxidase A (MAO-A) inhibitors.
    Thull U; Kneubühler S; Testa B; Borges MF; Pinto MM
    Pharm Res; 1993 Aug; 10(8):1187-90. PubMed ID: 8415406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
    Green AL; McGachy HA
    J Pharm Pharmacol; 1987 May; 39(5):392-4. PubMed ID: 2886590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoamine oxidase. I. Specificity of some substrates and inhibitors.
    Williams CH
    Biochem Pharmacol; 1974 Feb; 23(3):615-28. PubMed ID: 4822746
    [No Abstract]   [Full Text] [Related]  

  • 48. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA; Feor K
    Biochem Pharmacol; 1978; 27(11):1606-8. PubMed ID: 697902
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ
    Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of monoamine oxidation in rat liver mitochondria.
    Basu PS
    Biochem Pharmacol; 1975 Dec; 24(24):2269-71. PubMed ID: 1218099
    [No Abstract]   [Full Text] [Related]  

  • 51. Some structural requirements for inhibition of type A and B forms of rabbit monoamine oxidase by tricyclic psychoactive drugs.
    Roth JA; Gillis CN
    Mol Pharmacol; 1975 Jan; 11(1):28-35. PubMed ID: 1117864
    [No Abstract]   [Full Text] [Related]  

  • 52. Specificity of the learned helplessness model of depression.
    Sherman AD; Sacquitne JL; Petty F
    Pharmacol Biochem Behav; 1982 Mar; 16(3):449-54. PubMed ID: 7200610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria.
    Egashira T; Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibition of monoamine oxidase by amphetamine and related compounds.
    Mantle TJ; Tipton KF; Garrett NJ
    Biochem Pharmacol; 1976 Sep; 25(18):2073-7. PubMed ID: 985546
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of type A monoamine oxidase in mouse and rabbit liver mitochondria.
    Suzuki O; Mizutani S; Katsumata Y; Oya M
    Experientia; 1981 Jan; 37(1):18-9. PubMed ID: 6781927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.
    Neff NH; Yang HY; Fuentes JA
    Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330
    [No Abstract]   [Full Text] [Related]  

  • 57. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of psychotropic drugs on monoamine oxidase activity in individual nuclei of hypothalamus and amygdala in rat.
    Hazama H; Ito M
    Yonago Acta Med; 1976 Dec; 20(3):221-4. PubMed ID: 1032860
    [No Abstract]   [Full Text] [Related]  

  • 59. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 60. Preferential inhibition of type B-MAO by new compounds, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1h-indazole(Fs32) and its N-desmethylated derivative (FS97).
    Koide T; Uyemura K
    Neuropharmacology; 1980 Sep; 19(9):871-5. PubMed ID: 7422097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.